Artificial Intelligence System for Detecting Multiple Diseases Through Retinal Imaging - Summary - MDSpire

Artificial Intelligence System for Detecting Multiple Diseases Through Retinal Imaging

  • By

  • Xiayin Zhang

  • Qinyi Li

  • Yinhao Liang

  • Chunran Lai

  • Jiahui Cao

  • Yangqin Feng

  • Wenyi Hu

  • Hongyang Jiang

  • Chunxin Liu

  • Feng Zhang

  • Shan Wang

  • Ying Fang

  • Cuomu Duojie

  • Lumei Hu

  • Fan Xu

  • Kaiyi Chi

  • Miao Lin

  • Li Li

  • Yih Chung Tham

  • Yukun Zhou

  • Carol Y. Cheung

  • Xiaohong Yang

  • Bin Sheng

  • Zhuoting Zhu

  • Ching-Yu Cheng

  • Wing W. Y. Ng

  • Honghua Yu

  • April 28, 2026

  • 0 min

Share

Objective:

Emphasize the significance of addressing gaps in current screening methods.

Key Findings:
  • Include AUROC values for all diseases tested for completeness.
Interpretation:

Elaborate on how Reti-Pioneer specifically addresses current screening gaps.

Limitations:
  • Expand to include potential biases in dataset selection.
Conclusion:

Reiterate the practical implications of deploying Reti-Pioneer in clinical settings.

Original Source(s)

Artificial Intelligence System for Detecting Multiple Diseases Through Retinal Imaging

  • by Xiayin Zhang, Qinyi Li, Yinhao Liang, Chunran Lai, Jiahui Cao, Yangqin Feng, Wenyi Hu, Hongyang Jiang, Chunxin Liu, Feng Zhang, Shan Wang, Ying Fang, Cuomu Duojie, Lumei Hu, Fan Xu, Kaiyi Chi, Miao Lin, Li Li, Yih Chung Tham, Yukun Zhou, Carol Y. Cheung, Xiaohong Yang, Bin Sheng, Zhuoting Zhu, Ching-Yu Cheng, Wing W. Y. Ng, Honghua Yu

  • April 28, 2026

Related Content

Update on Diabetic Disease

Upfront: Monthly reflection by Editor in Chief Diana V. Do, MD.

Diabetes Risk Scores: Beyond Glucose

Multi-ancestry polygenic models identify high-risk patients traditional screening may miss.

Semaglutide Linked to NAION Risk

A retrospective database study found a low absolute incidence but higher relative hazard of ischemic optic neuropathy following semaglutide initiation.